CCM
Callodine Capital Management Portfolio holdings
AUM
$966M
This Quarter Return
+4.04%
1 Year Return
+10.47%
3 Year Return
+39.12%
5 Year Return
+80.3%
10 Year Return
–
AUM
$265M
AUM Growth
+$265M
(+15%)
Cap. Flow
+$23.6M
Cap. Flow
% of AUM
8.9%
Top 10 Holdings %
Top 10 Hldgs %
48.44%
Holding
44
New
8
Increased
17
Reduced
14
Closed
3
Top Buys
| 1 |
Ares Management
ARES
|
$7.19M |
| 2 |
Haemonetics
HAE
|
$6.66M |
| 3 |
Vistra
VST
|
$6.47M |
| 4 |
Citigroup
C
|
$4.95M |
| 5 |
Gilead Sciences
GILD
|
$3.79M |
Top Sells
| 1 |
DXC Technology
DXC
|
$5.84M |
| 2 |
Newmont
NEM
|
$4.91M |
| 3 |
Sally Beauty Holdings
SBH
|
$4.47M |
| 4 |
KKR & Co
KKR
|
$4.15M |
| 5 |
FSKR
FS KKR Capital Corp. II
FSKR
|
$4M |
Sector Composition
| 1 | Financials | 50.24% |
| 2 | Healthcare | 17.08% |
| 3 | Consumer Staples | 6.81% |
| 4 | Technology | 5.89% |
| 5 | Communication Services | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ares Management
ARES
$39.3B
| $19.3M | 7.27% | 303,096 +113,096 | +60% | +$7.19M |
|
2
Bristol-Myers Squibb
BMY
$96B
| $18.5M | 7% | 277,500 +15,000 | +6% | +$1M |
|
3
Radian Group
RDN
$4.72B
| $17.9M | 6.77% | 806,601 -48,399 | -6% | -$1.08M |
|
4
Fidelity National Information Services
FIS
$36.5B
| $12.4M | 4.68% | 87,500 +2,500 | +3% | +$354K |
|
|
5
Vistra
VST
$64.1B
| $11.6M | 4.37% | 623,750 +348,750 | +127% | +$6.47M |
|
6
Wells Fargo
WFC
$263B
| $10.2M | 3.84% | 225,000 | – | – |
|
|
PNNT
7
Pennant Park Investment Corp
PNNT
$468M
| $10M | 3.78% | 1,500,000 +207,570 | +16% | +$1.39M |
|
8
Viatris
VTRS
$12.3B
| $9.82M | 3.7% | 686,914 -20,000 | -3% | -$286K |
|
|
9
Gilead Sciences
GILD
$140B
| $9.64M | 3.64% | 140,000 +55,000 | +65% | +$3.79M |
|
10
Equitable Holdings
EQH
$16B
| $8.98M | 3.39% | 295,000 +80,000 | +37% | +$2.44M |
|
11
Sixth Street Specialty
TSLX
$2.3B
| $8.88M | 3.35% | 400,000 +150,000 | +60% | +$3.33M |
|
12
Altria Group
MO
$113B
| $8.85M | 3.34% | 185,641 -39,359 | -17% | -$1.88M |
|
13
Carlyle Group
CG
$23.4B
| $8.83M | 3.33% | 190,000 -75,000 | -28% | -$3.49M |
|
14
Carlyle Secured Lending
CGBD
$1.02B
| $7.93M | 2.99% | 600,000 -72,065 | -11% | -$952K |
|
15
FS KKR Capital
FSK
$5.11B
| $7.8M | 2.94% | 362,663 +139,273 | +62% | +$3M |
|
16
T-Mobile US
TMUS
$284B
| $6.88M | 2.6% | 47,500 +17,500 | +58% | +$2.53M |
|
|
17
Newmont
NEM
$81.7B
| $6.81M | 2.57% | 107,500 -77,500 | -42% | -$4.91M |
|
|
18
Haemonetics
HAE
$2.63B
| $6.66M | 2.51% | +100,000 | New | +$6.66M |
|
19
Verizon
VZ
$186B
| $6.58M | 2.48% | 117,500 -40,000 | -25% | -$2.24M |
|
20
Laird Superfood
LSF
$61.7M
| $6.37M | 2.4% | 213,156 | – | – |
|
21
Trinity Capital
TRIN
$1.14B
| $6.01M | 2.27% | 415,000 +225,000 | +118% | +$3.26M |
|
22
Barings BDC
BBDC
$1.04B
| $5.44M | 2.05% | 515,000 +165,000 | +47% | +$1.74M |
|
23
Stellantis
STLA
$27.8B
| $5.32M | 2.01% | 270,000 -85,847 | -24% | -$1.69M |
|
|
24
Citigroup
C
$178B
| $4.95M | 1.87% | +70,000 | New | +$4.95M |
|
25
SLR Investment Corp
SLRC
$907M
| $4.75M | 1.79% | 255,000 +130,000 | +104% | +$2.42M |
|